The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.

The aim of this study was to compare the effectiveness and the costs of three types of population interventions to increase the number of female participants in the screening programmes for cancer of the cervix carried out by Primary Care in four Basic Health Care Areas.

Condition or disease

Intervention/treatment

Uterine Cervical Neoplasms

Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer

Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer

Cost-effectiveness analysis of 3 strategies to increase the recruitment of population screening for cervical cancer. These interventions will be compared to the current opportunistic screening strategy

Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer

Cost-effectiveness analysis of 3 strategies to increase the recruitment of population screening for cervical cancer. These interventions will be compared to the current opportunistic screening strategy

Other Name: Cricerva

Experimental: Invitation letter and informative leaflet

to participate in the screening

Other: Different alternatives to improve the coverage of the populational screening programmes of cervical cancer

Cost-effectiveness analysis of 3 strategies to increase the recruitment of population screening for cervical cancer. These interventions will be compared to the current opportunistic screening strategy

The main effectiveness measures of this evaluation would be the total number of cytologies performed, HPV infections detected, lesions of different grades detected, episodes of cancer detected and the number of deaths avoided

Costs measures [ Time Frame: Third year ]

Include costs of diagnosis, interventions and treatment for all women

Diagnosis: cost of cytology, HPV determination test and control visit by the midwife or gynaecologist

Treatment: will depend on the state of health of the women but may include the costs of the visits to the gynaecologist, cytology tests, HPV determination, control visits with the physician, costs of radical hysterectomy, radiotherapy, chemotherapy, etc

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:

30 Years to 70 Years (Adult, Senior)

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Criteria

Inclusion Criteria:

20,994 women from 30 to 70 years of age with incorrect screening criteria (data obtained from Electronic Medical Records) ascribed to the Basic Health Care Area will be included in the study. Incorrect screening will be defined as [9]:

- No cytology in the last 3 years from women between 30 to 40 years,

- No cytology in the previous 5 years from women between 40 to 65 years,

- No previous cytology history for females older than 65 years or women who have not had their last cytology before the age of 60